News We are so proud of Dr. Jeff Infante, former Tennessee Oncology physician and key investigator for the Drug Development Unit at Sarah Cannon Research
Blog “The pace at which new therapies are moving brings hope that all blood cancer patients in the future will have great options for treatment.” – William Donnellan, M.D.
News Tennessee Oncology Appoints Dr. Stephen Schleicher as Chief Medical Officer and Promotes Dr. Natalie Dickson to President and Chief Strategy Officer